Related Experiment Video
Updated: Aug 11, 2026

09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Adverse events following immunization: assessing probability of causation
G M Fenichel1, D A Lane, J R Livengood
1Department of Neurology, Vanderbilt University, Nashville, TN 37232.
Pediatric Neurology
|September 1, 1989
Summary
Determining vaccine causation for adverse events is challenging. A new probability method combines epidemiology and patient history to estimate the odds of vaccine causation for serious neurologic events.
Area of Science:
- Epidemiology
- Biostatistics
- Neurology
Background:
- The Centers for Disease Control's Monitoring System for Adverse Events Following Immunization (AEFI) collects data on events post-vaccination.
- Neurologic disturbances are occasionally reported following immunization, but often occur independently of vaccination.
Observation:
- Distinguishing between causal and coincidental relationships between vaccines and neurologic events is difficult.
- Existing methods may be subject to observer bias.
Findings:
- A novel method using probability theory has been developed to assess vaccine causation for serious neurologic events.
- This method integrates epidemiologic data on disease incidence with patient-specific history.
- It provides a rational, evidence-based estimate of the odds of vaccine causation.
Implications:
- This approach offers a more objective way to evaluate potential vaccine-related adverse events.
- It aids in understanding the true incidence of vaccine-induced neurologic conditions.
- The method supports evidence-based public health policy regarding vaccine safety.
More Related Videos
Related Concept Videos
Vaccinations
Overview
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

